Related Experiment Video

Updated: Jul 14, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Itraconazole in Low-Risk Basal Cell Carcinoma: Stabilisation Before Downstaging

Haohao Wan1, Gen Quan1

  • 1Department of Dermatology, Wuhan Asia General Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.

Experimental Dermatology
|July 13, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CD105basal cell carcinomadisease stabilisationitraconazoletumour microenvironment

More Related Videos

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Related Experiment Videos

Last Updated: Jul 14, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

Articles linked to this work by shared authors, journal, and citation graph.

Topical Glucocorticoid-Induced Cushing's Syndrome in a Patient with Erythrodermic Psoriasis: A Case Report.

Clinical, cosmetic and investigational dermatology·2025

Analysis of factors affecting treatment adherence in patients with keloid disease.

Archives of dermatological research·2025

Drug rash with eosinophilia and systemic symptoms induced by valproate and carbamazepine: formation of circulating auto-antibody against 190-kDa antigen.

Acta dermato-venereologica·2006

TGF-beta1 up-regulates transglutaminase two and fibronectin in dermal fibroblasts: a possible mechanism for the stabilization of tissue inflammation.

Archives of dermatological research·2005

Chronic ultraviolet radiation modulates epidermal differentiation as it up-regulates transglutaminase 1 and its substrates.

Photodermatology, photoimmunology & photomedicine·2005

Differential Quantification of Cutibacterium acnes Phylotypes IA and IB/II on Healthy and Acne-Prone Human Skin.

Experimental dermatology·2026

Bullous Pemphigoid: A Focused Review on Antigen Epitopes.

Experimental dermatology·2026

Diet-Induced Obesity Promotes Alopecia Through Oxidative Stress and Androgen Signalling in Female Mice.

Experimental dermatology·2026

Antimicrobial Peptides of the Skin: Roles in Skin Cancer and Clinical Applications.

Experimental dermatology·2026

Gene Therapy for Dystrophic Epidermolysis Bullosa.

Experimental dermatology·2026

Repetin Regulates Epidermal Barrier Homeostasis and Is Associated With Inflammatory Skin Diseases.

Experimental dermatology·2026

Lost in Transition: A Case Study of Oral Baclofen Withdrawal Presenting as Severe Pain.

Cureus·2026

Cell Therapy in Advanced Cirrhosis: From Preclinical Evidence to Clinical Application.

Gastro hep advances·2026

BRCA1 deficiency in oocytes compromises ovulation without exacerbating follicle loss after chemotherapy in mice.

Reproductive biomedicine online·2026

Preclinical evaluation of Ayurveda and Siddha Herbo-mineral formulations in cancer: A scoping review protocol.

PloS one·2026

Inflammatory kinase TBK1 suppresses homologous recombination DNA repair to sensitize tumors to chemotherapy.

Proceedings of the National Academy of Sciences of the United States of America·2026

Haloperidol-Ondansetron versus Dexamethasone-Ondansetron for Prevention of Postoperative Nausea and Vomiting after Laparoscopic Gynecological Surgery: A Randomized Double-Blind Non-Inferiority Trial.

Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us